Tradestie Institutional Equity Comparison Engine

INSM vs CING โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-17 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

INSM Overall Edge

INSM Captures Institutional Edge (3โ€“1 Pillars ยท 6โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Insmed, Inc. (INSM) driven by superior Valuation, Momentum & Technical, Options & Structure while CING counters with relative strength in Growth & Margin. Fundamentally, INSM trades at N/M Forward P/E with -41.7% operating margin (+268.4% YoY revenue) versus CING at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, INSM sits in CONSOLIDATION (38th %ile IV; Dealer Gamma Walls on Pro) against CING sits in BREAKDOWN (16th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner INSM
INSM N/M vs CING N/M Fwd P/E
Growth & Margin Winner CING
Op Margin -41.7% vs 0.0% ยท YoY +268.4% vs +0.0%
Momentum & Technical Winner INSM
1Y -37.2% vs +35.4% ยท 52W Pos 25% vs 18%
Options & Structure Winner INSM
CONSOLIDATION (38th %ile IV) vs BREAKDOWN (16th %ile IV)
INSM NASDAQ
Insmed, Inc.
Pharmaceutical Preparations
$121.37
-1.23% 1D
Market Cap $26.6B
1M Return +27.37%
1Y Return -37.19%
Forward P/E N/M
Unified AI Score
34.3 / 100 SELL
Tech 50.0 Fund 33.0 Flow 68.0 Mom 40.0
CING NASDAQ
Cingulate Inc. Common Stock
Pharmaceutical Preparations
$4.72
+26.0% 1D
Market Cap $62.5M
1M Return +8.37%
1Y Return +35.39%
Forward P/E N/M
Unified AI Score
44.8 / 100 HOLD
Tech 31.0 Fund 50.0 Flow 67.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: INSM -37.19% CING +35.39% Spread: +72.58 pp (CING Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
INSM TTM Op. Margin: -41.7% CING TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on INSM vs CING. Trailing 12-month operating profitability (INSM -41.7% vs CING 0.0%) and valuation multiples (INSM N/M vs CING N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: INSM (6) vs CING (3)
Institutional Metric INSM CING Criterion Row Winner
Market Capitalization Scale $26.6B $62.5M Larger Scale INSM
Trailing P/E Ratio Valuation 107.5x N/M Lower Multiple INSM
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +268.4% +0.0% Higher Growth INSM
Operating Margin (TTM) Profitability -41.7% 0.0% Higher Margin CING
Net Profit Margin Profitability -39.9% 0.0% Higher Margin CING
Return on Equity (ROE) Capital Efficiency -72.5% -198.7% Higher ROE INSM
52-Week Range Position Momentum 25% ($90โ€“$213) 18% ($3โ€“$12) Stronger Trend INSM
Beta / 30D Volatility Risk Regime 0.66ฮฒ ยท 62% Vol 1.07ฮฒ ยท 121% Vol Lower Realized Risk INSM
Unified Institutional Score Composite Signal 34.3 / 100 (SELL) 44.8 / 100 (HOLD) Higher Composite CING

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full INSM vs CING Buy Guide
INSM CONSOLIDATION
70d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 38th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live INSM Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CING BREAKDOWN
170d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 16th %ile
IV Regime Compressed (<25th %ile)
Live CING Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither INSM nor CING registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.